Norinchukin Bank’s Merck MRK Stock Holding History

Norinchukin Bank’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$18.4M	Sell	153,343 -1,077	-0.7%	-$124K	0.22%	72
2025 Q4	$16.3M	Buy	154,420 +7,512	+5%	+$705K	0.19%	81
2025 Q3	$12.3M	Sell	146,908 -61	-0%	-$5.02K	0.17%	90
2025 Q2	$11.6M	Buy	146,969 +8,697	+6%	+$691K	0.17%	89
2025 Q1	$12.4M	Buy	138,272 +16,860	+14%	+$1.57M	0.23%	73
2024 Q4	$12.1M	Buy	121,412 +7,566	+7%	+$780K	0.26%	62
2024 Q3	$12.9M	Buy	113,846 +14,559	+15%	+$1.73M	0.31%	55
2024 Q2	$12.3M	Buy	99,287 +395	+0.4%	+$50.9K	0.35%	48
2024 Q1	$13M	Sell	98,892 -4,003	-4%	-$493K	0.39%	47
2023 Q4	$11.2M	Sell	102,895 -11,476	-10%	-$1.19M	0.26%	53
2023 Q3	$11.8M	Sell	114,371 -118,473	-51%	-$12.8M	0.28%	51
2023 Q2	$26.9M	Buy	232,844 +52,869	+29%	+$6M	0.45%	39
2023 Q1	$19.1M	Buy	179,975 +4,797	+3%	+$518K	0.38%	45
2022 Q4	$19.4M	Sell	175,178 -38,653	-18%	-$3.95M	0.42%	40
2022 Q3	$18.4M	Buy	213,831 +20,582	+11%	+$1.84M	0.38%	50
2022 Q2	$17.6M	Sell	193,249 -65,878	-25%	-$5.84M	0.34%	52
2022 Q1	$21.3M	Buy	259,127 +16,674	+7%	+$1.31M	0.28%	65
2021 Q4	$18.6M	Sell	242,453 -4,497	-2%	-$358K	0.23%	73
2021 Q3	$18.5M	Buy	246,950 +10,327	+4%	+$785K	0.26%	70
2021 Q2	$18.4M	Sell	236,623 -6,760	-3%	-$503K	0.27%	65
2021 Q1	$17.9M	Buy	243,383 +608	+0.3%	+$44.8K	0.25%	63
2020 Q4	$18.9M	Sell	242,775 -5,226	-2%	-$400K	0.27%	55
2020 Q3	$19.6M	Buy	248,001 +2,263	+0.9%	+$177K	0.31%	47
2020 Q2	$18.1M	Sell	245,738 -21,916	-8%	-$1.65M	0.31%	45
2020 Q1	$19.6M	Sell	267,654 -219,460	-45%	-$17.2M	0.38%	40
2019 Q4	$42.3M	Sell	487,114 -27,912	-5%	-$2.29M	0.55%	28
2019 Q3	$41.4M	Buy	515,026 +7,817	+2%	+$626K	0.58%	26
2019 Q2	$40.6M	Sell	507,209 -194,382	-28%	-$14.9M	0.62%	24
2019 Q1	$55.7M	Sell	701,591 -7,248	-1%	-$542K	0.71%	24
2018 Q4	$51.7M	Buy	708,839 +66,372	+10%	+$4.69M	0.72%	25
2018 Q3	$43.5M	Buy	642,467 +194	+0%	+$12.4K	0.59%	30
2018 Q2	$37.2M	Buy	642,273 +95,991	+18%	+$5.42M	0.56%	32
2018 Q1	$28.4M	Buy	546,282 +72,027	+15%	+$3.89M	0.48%	41
2017 Q4	$25.5M	Buy	474,255 +80,928	+21%	+$4.49M	0.45%	42
2017 Q3	$24M	Buy	393,327 +11,845	+3%	+$718K	0.47%	33
2017 Q2	$23.3M	Buy	381,482 +10,037	+3%	+$611K	0.48%	32
2017 Q1	$22.5M	Buy	371,445 +13,690	+4%	+$831K	0.49%	32
2016 Q4	$20.1M	Sell	357,755 -53,132	-13%	-$3.11M	0.47%	33
2016 Q3	$24.5M	Sell	410,887 -4,914	-1%	-$287K	0.59%	27
2016 Q2	$22.9M	Buy	415,801 +6,998	+2%	+$372K	0.56%	28
2016 Q1	$20.6M	Buy	408,803 +5,949	+1%	+$291K	0.5%	33
2015 Q4	$20.3M	Sell	402,854 -32,434	-7%	-$1.64M	0.52%	30
2015 Q3	$20.5M	Buy	435,288 +940	+0.2%	+$49.9K	0.54%	28
2015 Q2	$23.6M	Sell	434,348 -8,790	-2%	-$493K	0.6%	21
2015 Q1	$24.3M	Sell	443,138 -3,536	-0.8%	-$200K	0.59%	22
2014 Q4	$24.2M	Buy	446,674 +53,775	+14%	+$3M	0.59%	22
2014 Q3	$22.2M	Buy	392,899 +5,049	+1%	+$284K	0.63%	21
2014 Q2	$21.4M	Sell	387,850 -34,525	-8%	-$1.88M	0.63%	22
2014 Q1	$22.9M	Buy	422,375 +13,128	+3%	+$680K	0.65%	22
2013 Q4	$19.5M	Buy	409,247 +6,716	+2%	+$307K	0.53%	26
2013 Q3	$18.3M	Buy	402,531 +70,306	+21%	+$3.21M	0.52%	28
2013 Q2	$14.7M	Buy	+332,225	New	+$14.8M	0.45%	31

Other funds holding MRK

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Norinchukin Bank's MRK Position: Q1 2026 in Review

Norinchukin Bank reduced its Merck (MRK) stake by 0.7% in Q1 2026, selling an estimated $124K and leaving 153,343 shares worth $18.4M. The position accounts for 0.22% of the portfolio, ranked #72.

Norinchukin Bank first reported a position in MRK in Q2 2013 and has held it in 52 quarters since. The position peaked at $55.7M in Q1 2019. 3,778 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

Norinchukin Bank held 153,343 shares of Merck worth $18.4M as of Q1 2026.
Norinchukin Bank sold 1,077 Merck shares in Q1 2026, an estimated $124K.
Merck made up 0.22% of Norinchukin Bank's portfolio in Q1 2026, its #72 holding.
Norinchukin Bank first reported a position in Merck in Q2 2013 and has held it in 52 quarters since.
Norinchukin Bank's Merck position peaked at $55.7M in Q1 2019.
3,778 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Norinchukin Bank's 13F filing for Q1 2026, filed 15 May 2026.